Red yeast rice in the EU: the 2026 ban explained

The short answer

Red yeast rice with monacolins is on its way out of the EU. EU countries voted for a full ban on 13 May 2026, and on 8 October 2026 the European Parliament failed to block it. What is left is a formality: the Commission adopts the regulation and publishes it in the Official Journal. It enters into force 20 days later, and products already on the market can then stay on sale for 12 more months.

The reason is simple. The substance that makes red yeast rice lower cholesterol, monacolin K, is the same molecule as lovastatin, a prescription statin. EFSA looked twice, in 2018 and 2025, and could not find a daily amount from supplements that it could call safe. If you take red yeast rice today, talk to your doctor about what to do instead. The rest of this guide explains the timeline, the warnings that are already mandatory, and which alternatives have an authorised cholesterol claim.

From health claim to ban: the timeline

We last checked on 4 November 2026; at that point the final regulation had not yet been published. We will update this page when it is.

Why EFSA could not call it safe

Red yeast rice is rice fermented with the mould Monascus purpureus. The fermentation produces monacolins, mostly monacolin K. In its lactone form, EFSA notes, monacolin K is identical to lovastatin, the active ingredient of authorised cholesterol medicines. A supplement with monacolins is therefore, in effect, a low-dose statin sold without a prescription, without a doctor checking for interactions and without the quality controls of a medicine.

In its 2025 opinion EFSA’s nutrition panel reviewed the industry’s new data, including adverse-event reports and clinical studies, and kept its conclusion: exposure to monacolin K as low as 3 mg a day could lead to severe effects on the muscles, including rhabdomyolysis, and on the liver. The data did not allow it to establish safety below 3 mg a day or to identify a daily amount from supplements that does not raise safety concerns, for the general population or for vulnerable groups.

Quality is a second problem:

• The dose varies. Monacolin content depends on the strain and the fermentation, and red yeast rice contains other monacolins whose effects have not been assessed.
• Citrinin. Some Monascus strains produce citrinin, a mycotoxin that harms the kidneys. EU law caps it at 100 µg per kg in red yeast rice supplements.
• Market checks find problems. According to the German consumer organisation Verbraucherzentrale, Belgian authorities tested 35 red yeast rice supplements bought online in 2024. At least 4 raised serious safety concerns, 3 were probably adulterated, and about a third of the platform samples had labelling defects.
• Japan, 2024. Kobayashi Pharmaceutical recalled its red yeast rice supplements after kidney problems; the company reported deaths and over a hundred hospitalisations within the first weeks, and found puberulic acid, a toxin from a different mould, in batches from one factory. That was contamination, not monacolin, but it shows how much depends on production.

What the label must say until the ban applies

Until the new regulation applies and the sell-off period ends, a red yeast rice supplement sold in the EU must follow Regulation (EU) 2022/860:

• The daily portion must give less than 3 mg of monacolins, and the label must state the monacolin content per portion and the maximum number of portions a day.
• It must warn that the product should not be taken by pregnant or breastfeeding women, people under 18 or adults over 70.
• It must say not to take it with cholesterol-lowering medicines, and not together with other products containing red yeast rice.
• It must advise you to ask a doctor if you experience any health problems.

If a product sold in the EU lacks these warnings, or promises to “lower cholesterol”, it does not comply. The cholesterol claim was removed in 2024, so no red yeast rice product may make it any more. Our guide to how to read an EU supplement label explains where these statements sit on the pack.

In the UK: the 2022 limits and warnings apply in Northern Ireland but, according to the Department of Health and Social Care, never applied in Great Britain. A product bought from a GB shop may therefore contain more monacolins and carry fewer warnings.

If you take red yeast rice now

• Talk to your doctor or pharmacist before you stop or carry on, especially if you started it because a cholesterol test was high. Whether you need treatment depends on your overall heart risk, not on one number.
• Never combine it with a statin or another cholesterol medicine. That is exactly the combination the warnings exist for.
• Know the warning signs. Stop and see a doctor if you get unexplained muscle pain, cramps or weakness, dark urine, or yellowing skin or eyes.
• Check combination products. Red yeast rice is often hidden in “cholesterol” blends with CoQ10, policosanol or artichoke. Our CoQ10 page covers those combinations.

What has an authorised cholesterol claim instead

These ingredients may legally claim to help keep blood cholesterol normal, each at a fixed daily amount:

Three things to know about this table:

• The size of the effect (“7–10 %”) may only be stated on spreads, dairy products, mayonnaise and dressings, not on capsules. A sterol supplement can still use the claim, just without the percentage.
• Plant sterols carry their own warnings under EU labelling law: they are meant only for people who want to lower their cholesterol, people on cholesterol medicines should take them only under medical supervision, and you should not take more than 3 g a day.
• None of these replaces a medicine when a doctor has decided you need one. They are food-level effects.

Fish oil is not on the list for cholesterol. Its EU claim at 2 g of EPA and DHA a day is about triglycerides, a different blood fat; our omega-3 page has the details. The full wording of every authorised claim is in our table of EU health claims.

Checklist

1. Red yeast rice in the ingredients? Check the monacolin content per daily dose (must be below 3 mg) and the warnings. No warnings on a product sold in the EU: don’t buy it.
2. Taking a statin or another cholesterol medicine? No red yeast rice, and plant sterols only with your doctor’s agreement.
3. Over 70, under 18, pregnant or breastfeeding? Red yeast rice is not for you, according to the mandatory EU warning.
4. Want a cholesterol product with a legal claim? Look for beta-glucan (3 g), plant sterols or stanols (0.8 g, or 1.5–3 g to lower) or glucomannan (4 g), and check the daily amount on the label.